Skip to content
OpenCapital
Get started

NAGE NAGE EBITDA margin

EBITDA margin at other companies

Nature's Sunshine Products logo
Nature's Sunshine ProductsNATR
8.5%+0.6pp
Lifevantage Corporation logo
Lifevantage CorporationLFVN
4.8%-2.5pp
Biote Corp. logo
Biote Corp.BTMD
17.4%+0.1pp
NuSkin Enterprises logo
NuSkin EnterprisesNUS
9%+6.4pp
USANA Health Sciences logo
USANA Health SciencesUSNA
7.4%-1.4pp
BellRing Brands logo
BellRing BrandsBRBR
13.3%-7.3pp

Other financials

Income statement

See full
Revenue$31.5M+3.3%
Gross profit$20.0M+3.3%
Operating income$1.6M-67.0%
Net income$6.3M+24.8%
EPS (diluted)$0.07+16.7%

Balance sheet

See full
Cash & equivalents$66.5M+19.7%
Total debt$2.6M-26.9%
Total equity$82.3M+48.8%
Total assets$114.3M+40.6%

Cash flow

See full
Operating cash flow-$1.2M-115%

Valuation

See full
Market cap$254.07M-76.7%
Enterprise value$190.09M-81.6%
P/E13.6×-47.8×
P/S2×-7.4×

Profitability

See full
Gross margin64.3%+1.8pp
Operating margin10%-2.2pp
Net margin14.3%+1.2pp
FCF margin-70.4%—

Returns & leverage

See full
Return on equity27.1%-6.4pp
Debt / equity0×0.0×
Current ratio4.6×+0.9×

Where this comes from

Calculated from NAGE’s reported figures.

ebitda/total revenue=10.7%

Based on trailing twelve months.

The official record: NAGE’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about NAGE's ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NAGE's EBITDA margin?
NAGE (NAGE) reported EBITDA margin of 10.7% in Q1 2026.
How has NAGE's EBITDA margin changed year-over-year?
NAGE's EBITDA margin decreased by 17.6% year-over-year, from 13% to 10.7%.
What is the long-term trend for NAGE's EBITDA margin?
Over 3 years (2021 to 2025), NAGE's EBITDA margin has grown at a -30.0% compound annual growth rate (CAGR), from -38.5% to 13.2%.
What does EBITDA margin mean?
EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.